United States · FDA National Drug Code directory
NICOTINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82966-002_cf7fbe21-9a76-4832-88a4-2ef371510784
- Product NDC
- 82966-002
- Form
- LOZENGE
- Composition / generic term
- NICOTINE POLACRILEX MINI
- Labeler
- BLIP PRODUCTS, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230106
- Source listing expiry
- 20261231
Source-listed ingredients
- NICOTINE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 CONTAINER in 1 CARTON (82966-002-81) / 27 LOZENGE in 1 CONTAINER · 82966-002-81
- 1 CONTAINER in 1 CARTON (82966-002-83) / 27 LOZENGE in 1 CONTAINER · 82966-002-83
- 3 CONTAINER in 1 CARTON (82966-002-84) / 27 LOZENGE in 1 CONTAINER · 82966-002-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →